Authors: Hakimelahi, GH Ly, TW Yu, SF Zakerinia, M Khalafi-Nezhad, A Soltani, MN Gorgani, MN Chadegani, AR Moosavi-Movahedi, AA

Citation: Gh. Hakimelahi et al., Design and synthesis of a cephalosporin-retinoic acid prodrug activated bya monoclonal antibody-beta-lactamase conjugate, BIO MED CH, 9(8), 2001, pp. 2139-2147

Authors: Amirghofran, Z Zakerinia, M Shamseddin, A

Citation: Z. Amirghofran et al., Significant association between expression of the CD11b surface molecule and favorable outcome for patients with acute myeloblastic leukemia, INT J HEMAT, 73(4), 2001, pp. 502-506

Authors: Khojasteh, HN Zakerinia, M Ramzi, M Haghsenas, M

Citation: Hn. Khojasteh et al., Marrow transplantation in advanced thalassemic patients using a new conditioning regimen, TRANSPLAN P, 33(5), 2001, pp. 2862-2862

Authors: Hakimelahi, GH Ly, TW Moosavi-Movahedi, AA Jain, ML Zakerinia, M Davari, H Mei, HC Sambaiah, T Moshfegh, AA Hakimelahi, S

Citation: Gh. Hakimelahi et al., Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses, J MED CHEM, 44(22), 2001, pp. 3710-3720

Authors: Khojasteh, NH Zakerinia, M Ramzi, M Haghshenas, M

Citation: Nh. Khojasteh et al., A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients, TRANSPLAN P, 32(3), 2000, pp. 596-596

Authors: Khojasteh, NH Zakerinia, M Ramzi, M Haghshenas, M

Citation: Nh. Khojasteh et al., Results of allogeneic bone marrow transplantation in 90 patients at a university hospital in southern Iran, TRANSPLAN P, 32(3), 2000, pp. 597-597